{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:28:45Z","timestamp":1790494125216,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.04.084","type":"journal-article","created":{"date-parts":[[2016,5,7]],"date-time":"2016-05-07T18:18:12Z","timestamp":1462645092000},"page":"3076-3081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Novel nanocarrier for oral Hepatitis B vaccine"],"prefix":"10.1016","volume":"34","author":[{"given":"Amit K.","family":"Dinda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusudan","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarat K.","family":"Kottarath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandravilas K.","family":"Prashant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2016.04.084_bib0100","doi-asserted-by":"crossref","first-page":"e1003467","DOI":"10.1371\/journal.ppat.1003467","article-title":"Emerging infectious diseases: threats to human health and global stability","volume":"9","author":"Morens","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0105","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.addr.2012.10.005","article-title":"Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells","volume":"65","author":"Kwon","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0110","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/17425247.3.6.747","article-title":"Delivery systems and adjuvants for oral vaccines","volume":"6","author":"Lavelle","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0115","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/IAI.71.5.2356-2364.2003","article-title":"Oral immunization with a recombinant malaria protein induces conformational antibodies and protects mice against lethal malaria","volume":"71","author":"Wang","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0120","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.micinf.2004.08.010","article-title":"Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies","volume":"6","author":"Rauthan","year":"2004","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1711.2005.01335.x","article-title":"Oral hepatitis B vaccine candidates produced and delivered in plant material","volume":"83","author":"Streatfield","year":"2005","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0130","first-page":"1","article-title":"Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery","volume":"9","author":"Farhadian","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1049\/iet-nbt.2013.0035","article-title":"Poly (vinyl alcohol)-coated chitosan microparticles act as an effective oral vaccine delivery system for hepatitis B vaccine in rat model","volume":"8","author":"Shrestha","year":"2014","journal-title":"IET Nanobiotechnol"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10611861003733946","article-title":"Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B","volume":"19","author":"Mishra","year":"2011","journal-title":"J Drug Target"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0145","first-page":"937","article-title":"Fabrication of nanoadjuvant with poly-(-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity","volume":"9","author":"Prashant","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(99)00109-X","article-title":"Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery","volume":"184","author":"Benoit","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.humpath.2014.09.003","article-title":"A comparative study on renal biopsy before and after long-term calcineurin inhibitors therapy: an insight for pathogenesis of its toxicity","volume":"46","author":"Singh","year":"2015","journal-title":"Human Pathol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.04.084_bib0160","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.progpolymsci.2010.04.002","article-title":"The return of a forgotten polymer: polycaprolactone in the 21st century","volume":"35","author":"Woodruff","year":"2010","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajps.2014.12.007","article-title":"Developments of mucus penetrating nanoparticles","volume":"10","author":"Liu","year":"2015","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0170","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/1061186X.2014.897708","article-title":"Preparation of vincristine sulfate-loaded poly (butylcyanoacrylate) nanoparticles modified with pluronic F127 and evaluation of their lymphatic tissue targeting","volume":"22","author":"Tan","year":"2014","journal-title":"J Drug Target"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0175","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.vaccine.2003.11.064","article-title":"Pluronic\u00ae F127-based systemic vaccine delivery systems","volume":"22","author":"Claire","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0180","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0928-0987(97)10007-0","article-title":"Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia","volume":"6","author":"McClean","year":"1998","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0185","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2567.1999.00824.x","article-title":"Visualizing the T-cell response elicited by oral administration of soluble protein antigen","volume":"97","author":"Wlliamson","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2016.04.084_bib0190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1057","article-title":"Anatomical basis of tolerance and immunity to intestinal antigens","volume":"3","author":"Mowat","year":"2003","journal-title":"Nat Rev Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T07:28:24Z","timestamp":1536737304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16302584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":19,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16302584"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel nanocarrier for oral Hepatitis B vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}